ABiC Case Study Series

Interim 24-Month Data

Mark J. Gallardo, MD (USA)

Retrospective analysis, single-center, non-randomized study to demonstrate the efficacy and safety of ABiC in reducing IOP and glaucoma medication dependence in patients with uncontrolled, mild to moderate primary open angle glaucoma (POAG). At 24 months postoperatively there was a 39.06% reduction in mean IOP, as compared to baseline, and a 70.15% reduction in the mean number of medications.

(Interim data only. Not published)

ABiC Case Study Series

Interim 18-Month Data

Mahmoud A. Khaimi, MD (USA)

Retrospective analysis, single-center, non-randomized study involving 59 patients with mild to moderate primary open angle glaucoma (POAG). At 18 months postoperatively there was a 23.6% reduction in mean IOP, as compared to baseline, combined with a 64.8% reduction in the mean number of medications.
(Interim data only. Not published.)

ABiC Case Study Series

12-Month Data

Professor Norbert Koerber FEBO (Germany)

Twenty-three patients (23 eyes) were enrolled in the study. Mean IOP reduced from 18.8 ± 5.63 mm Hg preoperatively to 14.73 ± 2.97 (n=11) at 12 months postoperatively. Follow-up data beyond 6 months postoperative was only available for half of the total number of patients who underwent ABiC. The mean number of medications was reduced from 1.69 preoperatively to 0.21 at the last follow-up visit.

(Koerber N. Kanaloplastk ab interno – eine minimalinvasive Alternative. Klin Monatsbl Augenheikld. December 2017.)

American Society of Cataract & Refractive Surgery (ASCRS) 2017
Ab-Interno Canaloplasty as a Standalone Treatment and in Adjunct to Cataract Surgery for the treatment of Primary Open-Angle Glaucoma – Paper Abstract

Mahmoud A. Khaimi, MD (USA)


American Society of Cataract & Refractive Surgery (ASCRS) 2017
Twelve-month efficacy and safety outcomes with ab-interno canaloplasty (ABiC) versus traditional canaloplasty in primary open-angle glaucoma – Paper Abstract

Mark J. Gallardo, MD (USA)


American Society of Cataract & Refractive Surgery (ASCRS) 2017
Twelve-month outcomes of ab-interno canaloplasty for mild-to-moderate controlled and uncontrolled glaucoma – Paper Abstract

Mark J. Gallardo, MD (USA)


World Glaucoma Congress (WGC) 2017 – Paper Abstract
Efficacy of ab-interno Canaloplasty (ABiC) in patients with primary open-angle glaucoma

Professor Norbert Körber FEBO (Germany)


European Society of Cataract & Refractive Surgery (ESCRS) 2017
Ab-Interno Canaloplasty for the Treatment of Glaucoma: A Case Series Study – Paper Abstract

Professor Norbert Körber FEBO (Germany)


European Society of Cataract & Refractive Surgery (ESCRS) 2017
Comparing Ab-interno Canaloplasty (ABiC) as a Standalone Treatment and in Adjunct to Cataract Surgery for the treatment of Primary Open-Angle Glaucoma – Paper Abstract
Mahmoud A. Khaimi, MD (USA)


European Society of Cataract & Refractive Surgery (ESCRS) 2017
Ab-interno Canaloplasty (ABiC) in one eye versus traditional canaloplasty in the fellow eye: a twelve-month follow-up of patients with primary open-angle glaucoma – Paper Abstract

Mark J. Gallardo, MD (USA)


European Society of Cataract & Refractive Surgery (ESCRS) 2017
Ab-interno canaloplasty (ABiC) for mild-to-moderate controlled and uncontrolled glaucoma: twelve-month outcomes – Paper Abstract

Mark J. Gallardo, MD (USA)